Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Muscle aging and response to exercise in older adults with multiple sclerosis

Official title: Skeletal Muscle Aging and Responsiveness in Aged People With MS

Run by Oklahoma Medical Research Foundation · NCT07500727 · Data updated 2026-11-12

This study will test whether a combined cardio and strength exercise program improves muscle health and fitness for people with MS who are 60 or older compared with similar people without MS.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment10 (estimated)
SponsorOklahoma Medical Research Foundation
Academic / other
Drugs / interventionsChemotherapy
Locations1 site (Oklahoma City, Oklahoma)
StatusRecruiting
StartedMarch 6, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMarch 30, 2026
Trial IDNCT07500727 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 60 or older with a diagnosis of MS, EDSS 2.0–5.5, cognitively able to consent, not currently in a structured exercise program, and without unmanaged chronic diseases are ideal candidates.

Probably not a fit

People with severe disability outside the EDSS range, unmanaged cardiopulmonary or metabolic diseases (including diabetes or liver disease), recent chemotherapy, those taking metformin, or other conditions that limit safe exercise are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The investigators will first compare baseline muscle and cardiovascular health in adults aged 60 and older with MS to age-matched people without MS. Participants will then complete a combined cardiovascular and resistance training program with visits about three times per week, roughly 1.5 hours per visit, for approximately four months. The study will measure whole-body and muscle-specific changes, including differences between a more affected and a less affected leg in people with MS, and cardiorespiratory fitness (VO2max). Results will show whether older adults with MS adapt to exercise differently than age-matched peers without MS.

Why it matters

Potential benefit: If successful, participants could gain stronger, healthier muscles, better cardiovascular fitness, and improved day-to-day mobility.

How similar studies have gone: Exercise trials in younger and middle-aged people with MS have shown benefits for strength and fitness, but few studies have focused on people over 60, so this approach is partly supported but relatively novel in this age group.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\. Male or female aged 60 or above 2. Free of unmanaged chronic diseases other than multiple sclerosis 3. No structured exercise program (2 or more bouts/wk) within previous 6 months 4. Cognitively capable of providing informed consent 5. Must meet EDSS score between 2 to 5.5 during screening

Exclusion Criteria:

* 1\. Neuromuscular or musculoskeletal disorder, other than multiple sclerosis, that would limit the ability to perform the exercise and/or testing bouts.

  2\. Cardiopulmonary disorders or reduced breathing capacity

  3\. Metabolic diseases including markers of liver disease (ALT \> 52 U/dl) and type 2 diabetes (HbA1C ≥ 6.5, fasting blood glucose ≥ 126 mg/dl)

  4\. Taking any dose of metformin

  5\. Any other disease or disorder that would influence exercise response (e.g., chronic kidney disease, Alzheimer's, current cancer diagnosis or within 2 yr remission, cerebrovascular)

  6\. History of Chemotherapy within 5 years

  7\. Unchangeable anticoagulant (Coumadin, Pradaxa, etc.) use. To be determined by clinical staff.

  8\. Insulin sensitizing/blood glucose lowering (e.g., metformin) or metabolic (GLP1 agonists) drugs.

  9\. High dose statin (40 mg and above)

  10\. Have a non-correctable visual impairment

  11\. Score less than 29 on the Symbol Digit Test

  12\. Received Botox for spasticity within the prior 3 months of study participation.

  13\. Cannot have any adjustments to Baclofen during study participation.

  13\. Unable to commit to \~4 months required to complete the study.

  14\. Lidocaine allergy

  15\. Tobacco use

  16\. Excessive alcohol consumption (3 drinks/d or 7 drinks/wk for females; 4 drinks/day or drinks/wk for males)

  17\. BMI greater than 35.0 kg/m2

Where it's running

  • Oklahoma Medical Research Foundation
    Oklahoma City, Oklahoma, United States
    Recruiting

Study contacts

  • Principal investigator: Benjamin F Miller, Ph.D. — Oklahoma Medical Research Foundation
  • Study coordinator: Lena Fuentes
  • Email: lena-fuentes@omrf.org
  • Phone: 4052717745

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.